Economic Conditions: Overall economic growth, interest rates, and inflation can significantly impact investor sentiment and corporate profitability, thus influencing stock prices.

Company Performance: Revenue, earnings, profit margins, and debt levels of the company directly affect investor confidence and the stock's valuation.

Industry Trends: The performance and outlook of the pharmaceutical industry, including regulatory changes and technological advancements, affect investor perception of the company.

Market Sentiment: General investor optimism or pessimism, often influenced by news events and macroeconomic factors, can drive stock prices up or down.

Regulatory Environment: Changes in government regulations, drug approvals, or healthcare policies can impact the company's operations and profitability.

Competition: The presence and actions of competitors in the pharmaceutical market, including pricing strategies and new product launches, can affect the company's market share and earnings.

Global Events: Geopolitical events, trade disputes, or global health crises can introduce uncertainty and volatility into the stock market, impacting stock prices.

Company News: Announcements related to new products, partnerships, acquisitions, or significant legal issues can influence investor perception and stock value.

Financial Reports: Quarterly and annual earnings reports provide insights into the company's financial health, influencing investment decisions.

Dividend Policy: The company's dividend payouts can attract income-seeking investors, potentially affecting stock demand and price.